Are surrogate markers adequate to assess cardiovascular disease drugs?

被引:218
作者
Temple, R [1 ]
机构
[1] US FDA, Ctr Drug Evaluat & Res Policy, Rockville, MD 20857 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1999年 / 282卷 / 08期
关键词
D O I
10.1001/jama.282.8.790
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:790 / 795
页数:8
相关论文
共 30 条
  • [21] DIURETIC THERAPY FOR HYPERTENSION AND THE RISK OF PRIMARY CARDIAC-ARREST
    SISCOVICK, DS
    RAGHUNATHAN, TE
    PSATY, BM
    KOEPSELL, TD
    WICKLUND, KG
    LIN, XH
    COBB, L
    RAUTAHARJU, PM
    COPASS, MK
    WAGNER, EH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (26) : 1852 - 1857
  • [22] Sobel BE, 1997, CIRCULATION, V95, P1661
  • [23] Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
    Staessen, JA
    Fagard, R
    Thijs, L
    Celis, H
    Arabidze, GG
    Birkenhager, WH
    Bulpitt, CJ
    deLeeuw, PW
    Dollery, CT
    Fletcher, AE
    Forette, F
    Leonetti, G
    Nachev, C
    OBrien, ET
    Rosenfeld, J
    Rodicio, JL
    Tuomilehto, J
    Zanchetti, A
    [J]. LANCET, 1997, 350 (9080) : 757 - 764
  • [24] TEMPLE R, 1990, DEV CARDIOVASC MED, P139
  • [25] TEMPLE R, 1988, P179
  • [26] TEMPLE R, 1987, CONGESTIVE HEART FAI, P155
  • [27] Temple Robert J., 1995, P3
  • [28] US Food and Drug Administration, 1992, FED REGISTER, V57, P13234
  • [29] *VET ADM COOP STUD, 1967, JAMA-J AM MED ASSOC, V202, P1228
  • [30] BETA-BLOCKADE DURING AND AFTER MYOCARDIAL-INFARCTION - AN OVERVIEW OF THE RANDOMIZED TRIALS
    YUSUF, S
    PETO, R
    LEWIS, J
    COLLINS, R
    SLEIGHT, P
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 1985, 27 (05) : 335 - 371